SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $165

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $158 to $165.

Benzinga · -

UBS maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $158 to $165.